Psychiatric disorders represent a great medical and social challenge and people suffering
from these conditions face many impairments regarding personal and professional life. In …

Background: Recent years have brought a resurgence of research interest in fatty acids, with
studied fields running the gamut of human disease. This movement has run in parallel with …

Schizophrenia is a severe mental disorder that affects 0.5–1% of the population worldwide.
Current diagnostic methods are based on psychiatric interviews, which are subjective in …

Despite the increasing global burden of neurological disorders, there is a lack of effective
diagnostic and therapeutic biomarkers. Proteins are often dysregulated in disease and have …

Background: Recent studies indicate the presence of mitochondrial dysfunction in brains of
subjects with bipolar disorder (BD). Because the mitochondrial electron transport chain is a …

Antipsychotic effects seem to decrease in relapsed schizophrenia patients and the
underlying mechanisms remain to be elucidated. Based on the essential role of …

BACKGROUND: Membrane lipids are important mediators of neuronal function. In a
postmortem study, we measured membrane lipid components in the left thalamus of …

Background Schizophrenia is a serious long-term psychotic disorder marked by positive and
negative symptoms, severe behavioral problems and cognitive function deficits. The cause …

Psychoactive drugs of fungal origin, psilocin, ibotenic acid, and muscimol among them have
been proposed for recreational use and popularized since the 1960s, XX century. Despite …

The identification of an ultra-high risk (UHR) profile for psychosis and a greater
understanding of its prodrome have led to increasing interest in early intervention to delay or …